Chronic hepatitis B and C infections are the most common risk factor for liver cancer.1 Together these diseases are estimated to account for 80% of liver cancer cases globally.2 In Australia, the prevalence of chronic hepatitis B is approximately 1%3, with a higher prevalence occurring in people born in certain other countries (e.g., Vietnam, Cambodia, China, Taiwan and Afghanistan) and in Aboriginal and Torres Strait Islander peoples.3,4 Studies indicate that the risk of developing liver cancer can be 20-30 times higher in people with chronic hepatitis infection than among the general population.5,6
22 Jun, 2022
In 2018, Hepatitis B immunisation coverage was recorded at 97.1% in Indigenous Australian children and 95.8% in their non-Indigenous counterparts.
Between 2013 and 2018, immunisation rates for Indigenous infants aged 12-15 months increased from around 87.3% to 95.6%.
The Hepatitis B immunisation coverage for Australian infants in 2018 was recorded at 95.9%, which is similar to that reported in most comparable countries. Almost all economically developed countries have an infant coverage rate above 90% for Hepatitis B.